TARAH WAFZIG: Open Payments
NPI 1124420237 · SHEPHERDSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,843 in 184 payments from 27 companies in 2025. Trend: 2023 $1,964 · 2024 $2,578 · 2025 $2,843
Food & beverage: $2,823Long term medical supply or device loan: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $450 |
| PFIZER INC. | 34 | $333 |
| Amgen Inc. | 26 | $281 |
| Novo Nordisk Inc | 17 | $217 |
| AstraZeneca Pharmaceuticals LP | 5 | $196 |
| Lilly USA, LLC | 14 | $156 |
| Medtronic, Inc. | 2 | $150 |
| Novartis Pharmaceuticals Corporation | 7 | $137 |
| Vanda Pharmaceuticals Inc. | 4 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $108 |
Products named: NURTEC ODT, VRAYLAR, BREZTRI, MINIMED 780G, LEQVIO, QULIPTA, Wegovy, HETLIOZ.
Industry payments across KY — which companies pay providers there.
